{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:54Z","timestamp":1793377914198,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.045","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:28:50Z","timestamp":1785367730000},"page":"5697-5709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Triple-AAV intein-mediated gene therapy ameliorates dystrophic phenotype in MDC1A mice"],"prefix":"10.1016","volume":"34","author":[{"given":"N\u00faria","family":"Rafel-Millan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Bayod-Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pallar\u00e8s-Masmitj\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keilisa","family":"Figuereo-Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0840-2111","authenticated-orcid":false,"given":"Miguel","family":"Chill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Vila-Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-7912","authenticated-orcid":false,"given":"Marc","family":"G\u00fcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.045_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.07.045_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JND-221552","article-title":"Estimating the Prevalence of LAMA2 Congenital Muscular Dystrophy using Population Genetic Databases","volume":"10","author":"Lake","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.07.045_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2004.06.009","article-title":"The congenital muscular dystrophies in 2004: a century of exciting progress","volume":"14","author":"Muntoni","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.07.045_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2026.07.045_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S0004-282X2009000100038","article-title":"Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects","volume":"67","author":"Reed","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ymthe.2026.07.045_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness","volume":"13","author":"Sarkozy","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/TACG.S187481","article-title":"Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-\u03b12 chain-deficient congenital muscular dystrophy","volume":"12","author":"Nguyen","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymthe.2026.07.045_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0037-1604154","article-title":"Congenital Muscular Dystrophies and Myopathies: An Overview and Update","volume":"48","author":"Schorling","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymthe.2026.07.045_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/cam.22826","article-title":"The laminin family","volume":"7","author":"Aumailley","year":"2013","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.ymthe.2026.07.045_bib10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00018-016-2381-0","article-title":"Laminin: loss-of-function studies","volume":"74","author":"Yao","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib11","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1242\/jcs.041095","article-title":"Laminin deposition in the extracellular matrix: a complex picture emerges","volume":"122","author":"Hamill","year":"2009","journal-title":"J. Cel Sci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.ctm.2015.05.002","article-title":"Laminin-\u03b12 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment","volume":"76","author":"Durbeej","year":"2015","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.ymthe.2026.07.045_bib13","doi-asserted-by":"crossref","first-page":"27664","DOI":"10.1074\/jbc.271.44.27664","article-title":"Structure of the Human Laminin \u03b12-Chain Gene (LAMA2), Which Is Affected in Congenital Muscular Dystrophy","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.045_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0945-053X(00)00072-X","article-title":"Structure and function of laminin LG modules","volume":"19","author":"Timpl","year":"2000","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2044-5040-1-9","article-title":"Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies","volume":"1","author":"Gawlik","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2026.07.045_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-510X(99)00012-X","article-title":"Secondary reduction of \u03b17B integrin in laminin \u03b12 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle","volume":"163","author":"Cohn","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197388","article-title":"Natural disease history of the dy2J mouse model of laminin \u03b12 (merosin)-deficient congenital muscular dystrophy","volume":"13","author":"Pasteuning-Vuhman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.07.045_bib18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1172\/JCI3705","article-title":"Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models","volume":"102","author":"Kuang","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.07.045_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2020.00001","article-title":"Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics","volume":"13","author":"Barraza-Flores","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/hmg\/ddh190","article-title":"Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice","volume":"13","author":"Gawlik","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.07.045_bib21","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddl201","article-title":"Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy","volume":"15","author":"Gawlik","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.07.045_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)62054-8","article-title":"Laminin {alpha}1 chain corrects male infertility caused by absence of laminin {alpha}2 chain","volume":"167","author":"H\u00e4ger","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/mus.21616","article-title":"Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan","volume":"42","author":"Gawlik","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.07.045_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.matbio.2018.02.024","article-title":"Laminin \u03b11 reduces muscular dystrophy in dy2J mice","volume":"70","author":"Gawlik","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/rmv.1762","article-title":"Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them","volume":"23","author":"Hareendran","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtm.2021.02.004","article-title":"Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A","volume":"21","author":"Packer","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.045_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.045_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.200611152","article-title":"Linker molecules between laminins and dystroglycan ameliorate laminin-\u03b12\u2013deficient muscular dystrophy at all disease stages","volume":"176","author":"Meinen","year":"2007","journal-title":"J. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib29","doi-asserted-by":"crossref","first-page":"11999","DOI":"10.1073\/pnas.0502137102","article-title":"Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin","volume":"102","author":"Qiao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.045_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.01.005","article-title":"Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin","volume":"9","author":"Qiao","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.045_bib31","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1074\/jbc.M809719200","article-title":"Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly","volume":"284","author":"McKee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.045_bib32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI90854","article-title":"Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype","volume":"127","author":"McKee","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.07.045_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158397","article-title":"Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-\u03b1LN linker protein","volume":"7","author":"McKee","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.07.045_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4649","article-title":"Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice","volume":"9","author":"Reinhard","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.045_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad083","article-title":"Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy","volume":"2","author":"Reinhard","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ymthe.2026.07.045_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-019-1430-x","article-title":"A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene","volume":"572","author":"Kemaladewi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.045_bib37","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.ymthe.2026.01.041","article-title":"Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy","volume":"34","author":"Reinhard","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.045_bib38","article-title":"CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy","author":"Arockiaraj","year":"2023","journal-title":"bioRxiv."},{"key":"10.1016\/j.ymthe.2026.07.045_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.matbio.2017.11.009","article-title":"Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies","volume":"71\u201372","author":"Yurchenco","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2026.07.045_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep45272","article-title":"Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells","volume":"7","author":"Fontes-Oliveira","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.045_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2020.00003","article-title":"Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology","volume":"13","author":"Accorsi","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib42","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.109.160754","article-title":"Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency","volume":"331","author":"Erb","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2026.07.045_bib43","article-title":"Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.07.045_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.07.045_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10258","article-title":"Viral vector-based gene therapies in the clinic","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.045_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2015.140","article-title":"Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids","volume":"27","author":"Chamberlain","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2026.07.045_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1607","article-title":"Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes","volume":"14","author":"Kolesnik","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.045_bib48","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41591-024-03023-5","article-title":"Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.045_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8122004","article-title":"Inteins in Science: Evolution to Application","volume":"8","author":"Nanda","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ymthe.2026.07.045_bib50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-020-15272-2","article-title":"An expanded library of orthogonal split inteins enables modular multi-peptide assemblies","volume":"11","author":"Pinto","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.045_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1039\/C3SC52951G","article-title":"Inteins: Nature\u2019s Gift to Protein Chemists","volume":"5","author":"Shah","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ymthe.2026.07.045_bib52","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1021\/jacs.7b02618","article-title":"Intein Zymogens: Conditional Assembly and Splicing of Split Inteins via Targeted Proteolysis","volume":"139","author":"Gramespacher","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.07.045_bib53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/hum.2008.009","article-title":"Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy","volume":"19","author":"Li","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.045_bib54","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.07.045_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.045_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202000309","article-title":"Development of highly efficient dual-AAV split adenosine base editor for in vivo gene therapy","volume":"4","author":"Chen","year":"2020","journal-title":"Small Methods"},{"key":"10.1016\/j.ymthe.2026.07.045_bib57","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1073\/pnas.1701083114","article-title":"A promiscuous split intein with expanded protein engineering applications","volume":"114","author":"Stevens","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.045_bib58","doi-asserted-by":"crossref","first-page":"11791","DOI":"10.1021\/jacs.8b07334","article-title":"An Atypical Mechanism of Split Intein Molecular Recognition and Folding","volume":"140","author":"Stevens","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.07.045_bib59","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.gt.3302979","article-title":"The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors","volume":"14","author":"Higashimoto","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.045_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13395-020-00235-4","article-title":"Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD","volume":"10","author":"Barraza-Flores","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2026.07.045_bib61","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1016\/j.febslet.2006.07.015","article-title":"Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy","volume":"580","author":"Hagiwara","year":"2026","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2026.07.045_bib62","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2026.09.028","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:35:55Z","timestamp":1793374555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006660"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.045","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple-AAV intein-mediated gene therapy ameliorates dystrophic phenotype in MDC1A mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}